With advertisers preparing to spend up to $15 billion on influencer marketing by 2022, pharmaceutical and biotech companies are increasingly (and carefully) engaging trusted health social influencers to connect more authentically with consumers.

As pharma starts to leverage a multitude of high-engagement channels like influencer marketing, online communities, and virtual health services, the industry finds itself in a unique position to reimagine traditional direct-to-consumer (DTC) efforts and peer-to-peer communication. That means going beyond TV ad celebrities or one-off Instagram relationships limited to short-term PR value.

Read the full article HERE


Back To All Blog Articles

Ready to learn why organizations like yours are
making the switch to Arize?

Let us know and we’ll send you an $11.00 Starbucks gift card so you can have a coffee
on us as we continue the conversation.